Zobrazeno 1 - 10
of 43
pro vyhledávání: '"H. David Friedland"'
Autor:
Shampa Das, Matthew Dryden, Joseph P. Iaconis, G. Ralph Corey, Mark H. Wilcox, Alena Jandourek, H. David Friedland, David J. Wilson, Jesus Gonzalez
Publikováno v:
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
This post-hoc analysis compared the pharmacokinetics and clinical outcomes of ceftaroline fosamil 600 mg every 12 (q12h) versus every 8 hours (q8h) in patients with acute bacterial skin and skin-structure infection (ABSSSI) and signs of sepsis. Clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b0ff02f27e95410f34d7fafb00cffd
Autor:
Christopher J. Kemper, Rajesh Chavan, Mushtaque Mastim, Ravindra D. Yeole, Ashima Bhatia, Allan Xu, H. David Friedland, Dyal C. Garg, Richard A. Preston, Grigor Mamikonyan
Publikováno v:
Antimicrobial agents and chemotherapy. 63(10)
WCK 4282 is a combination product of cefepime (FEP) and tazobactam (TAZ) in a 1:1 ratio currently under development for the treatment of multidrug-resistant Gram-negative bacterial infections. We investigated the effect of renal impairment on the pha
Autor:
Bartosz Korczowski, Tanya O'Neal, Alena Jandourek, H. David Friedland, Christopher R. Cannavino, Sheldon L. Kaplan, John S. Bradley, Agnes Nemeth
Publikováno v:
Pediatric Infectious Disease Journal. 35:752-759
Community-acquired bacterial pneumonia (CABP) remains a major infection among children, despite the use of pneumococcal vaccination. Ceftaroline fosamil is a broad-spectrum cephalosporin antibiotic with activity against many bacteria, including Strep
Autor:
Grigor Mamikonyan, Christopher J. Kemper, Stephane DeGraff, Allan Xu, Ashima Bhatia, Anasuya Patel, Mushtaque Mastim, Rajesh Chavan, James Chiou, Richard A. Preston, H. David Friedland, Ravindra D. Yeole
Publikováno v:
Antimicrobial agents and chemotherapy. 63(1)
WCK 5222 is a novel β-lactam–β-lactam-enhancer combination of cefepime (FEP) and zidebactam (ZID). ZID is a novel β-lactam enhancer with a dual action of binding to Gram-negative penicillin-binding protein 2 (PBP2) and β-lactamase inhibition. W
Autor:
Ravindra D. Yeole, Ashima Bhatia, Mugdha Gupta, Keith A. Rodvold, Anasuya Patel, Rakesh Chugh, Rajesh Chavan, H. David Friedland, Mark H. Gotfried
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
WCK 5222 is a combination of cefepime and the novel β-lactam enhancer zidebactam being developed for the treatment of serious Gram-negative bacterial infections. The objective of this study was to compare plasma (total), epithelial lining fluid (ELF
Autor:
Todd Riccobene, Sujata M. Bhavnani, Christopher M. Rubino, H. David Friedland, Alan Forrest, Scott A. Van Wart, Paul G. Ambrose, Daniel K. Reynolds, Tatiana Khariton, Jeffrey P. Hammel, George L. Drusano
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:372-380
Ceftaroline is a cephalosporin with broad-spectrum in vitro activity against pathogens commonly associated with acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus . Ceftaroline fosamil,
Publikováno v:
Expert Review of Clinical Pharmacology. 8:141-153
The Clinical Assessment Program and Teflaro(®) Utilization Registry (CAPTURE) is a multicenter retrospective study, conducted in the USA, describing the contemporary use of ceftaroline fosamil. Ceftaroline is primarily excreted by the kidneys and th
Autor:
H. David Friedland, Jose A. Vazquez, Phillip Cole, Alena Jandourek, Christy Maggiore, Alexander Smith
Publikováno v:
Infectious Diseases in Clinical Practice (Baltimore, Md.)
Staphylococcus aureus is a leading cause of community-associated and health care–associated bacteremia and is also associated with high morbidity and mortality.1 Although most cases of S. aureus bacteremia (SAB) result from medical interventions su
Autor:
Keith A. Rodvold, H. David Friedland, Mugdha Gupta, Ashima Bhatia, Mark H. Gotfried, Rakesh Chugh
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
The nafithromycin concentrations in the plasma, epithelial lining fluid (ELF), and alveolar macrophages (AM) of 37 healthy adult subjects were measured following repeated dosing of oral nafithromycin at 800 mg once daily for 3 days. The values of non
Autor:
H. David Friedland, Christopher M. Rubino, Scott A. Van Wart, Sujata M. Bhavnani, Ian A. Critchley, Todd Riccobene, Tatiana Khariton, Paul G. Ambrose
Publikováno v:
Antimicrobial Agents and Chemotherapy. 58:885-891
To provide support for in vitro susceptibility test interpretive criteria decisions for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae , as well as dose adjustment recommendations for renal impairment, pharmacokinetic-pharmaco